Tag: BIO CEO & Investor Conference
BIO CEO Company Snapshot: Tetraphase Pharmaceuticals
The BIO CEO & Investor Conference is now just a week away, and buzz for …
2013 Novel Drug Approvals
The FDA approved 24 novel drugs last year by our count, in line with average …
#BIOBuyside Twitter Chat: What Do Biotech Investors Expect in 2014?
Is 2014 a good time to invest in biotech? How many biotech IPOs will there …
What’s In Store for Biotechs at this Year’s CEO & Investor Conference
In just a few weeks, industry leaders will gather in New York for one of …
Couldn’t Make it to San Francisco This Week?
Me neither, so here is what I am reading for updates about the 32nd Annual JPMorgan Healthcare …
BIO White Paper Highlights Key Industry Legislation and its Impact on the Industry
Innovative biotech companies at all stages of the development process are working toward next generation …
What’s Behind the Biotech IPO Boom?
Everyone knows that it’s been a knock-out year for the biotech sector in the public …
The Value of Partnering Continues to be a Draw for BIO Events
Last month’s BIO Convention in China saw 700 partnering meetings between executives from biotechnology, pharmaceutical companies and investment …
Biotech Stocks Hit Record Highs...Again
Biotech stocks hit an all-time high this week, driven by strong performance among large cap …
Show Me the Money: Reimbursement in an ACA World
A panel at the BIO CEO & Investor Conference focused on reimbursement discussed value from a …